AMGN logo

Amgen Inc. (AMGN) Cash From Financing

Annual CFF:

-$9.41B-$30.46B(-144.73%)
December 31, 2024

Summary

  • As of today, AMGN annual cash from financing is -$9.41 billion, with the most recent change of -$30.46 billion (-144.73%) on December 31, 2024.
  • During the last 3 years, AMGN annual cash from financing has fallen by -$1.14 billion (-13.83%).
  • AMGN annual cash from financing is now -144.73% below its all-time high of $21.05 billion, reached on December 31, 2023.

Performance

AMGN Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNcash flow metrics

Quarterly CFF:

-$2.67B+$1.43B(+34.92%)
June 30, 2025

Summary

  • As of today, AMGN quarterly cash from financing is -$2.67 billion, with the most recent change of +$1.43 billion (+34.92%) on June 30, 2025.
  • Over the past year, AMGN quarterly cash from financing has dropped by -$24.00 million (-0.91%).
  • AMGN quarterly cash from financing is now -112.43% below its all-time high of $21.51 billion, reached on March 31, 2023.

Performance

AMGN Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNcash flow metrics

TTM CFF:

-$11.84B-$24.00M(-0.20%)
June 30, 2025

Summary

  • As of today, AMGN TTM cash from financing is -$11.84 billion, with the most recent change of -$24.00 million (-0.20%) on June 30, 2025.
  • Over the past year, AMGN TTM cash from financing has dropped by -$8.23 billion (-228.10%).
  • AMGN TTM cash from financing is now -156.24% below its all-time high of $21.05 billion, reached on December 31, 2023.

Performance

AMGN TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

AMGN Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-144.7%-0.9%-228.1%
3Y3 Years-13.8%-151.7%-42.9%
5Y5 Years+40.3%-444.9%-269.3%

AMGN Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-144.7%at low-112.4%+34.9%-156.2%at low
5Y5-Year-144.7%+40.3%-112.4%+59.2%-156.2%at low
All-TimeAll-Time-144.7%+58.1%-112.4%+77.1%-156.2%+47.4%

AMGN Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.67B(+34.9%)
-$11.84B(-0.2%)
Mar 2025
-
-$4.11B(-191.9%)
-$11.81B(-25.5%)
Dec 2024
-$9.41B(-144.7%)
-$1.41B(+61.5%)
-$9.41B(-79.2%)
Sep 2024
-
-$3.65B(-37.8%)
-$5.25B(-45.6%)
Jun 2024
-
-$2.65B(-55.1%)
-$3.61B(-66.3%)
Mar 2024
-
-$1.71B(-162.0%)
-$2.17B(-110.3%)
Dec 2023
$21.05B(+621.4%)
$2.75B(+237.4%)
$21.05B(+22.1%)
Sep 2023
-
-$2.00B(-65.7%)
$17.25B(-17.2%)
Jun 2023
-
-$1.21B(-105.6%)
$20.84B(-0.7%)
Mar 2023
-
$21.51B(+2150.4%)
$20.99B(+619.8%)
Dec 2022
-$4.04B(+51.2%)
-$1.05B(-166.1%)
-$4.04B(+57.7%)
Sep 2022
-
$1.59B(+249.5%)
-$9.55B(-15.2%)
Jun 2022
-
-$1.06B(+69.8%)
-$8.29B(+15.8%)
Mar 2022
-
-$3.51B(+46.4%)
-$9.85B(-19.0%)
Dec 2021
-$8.27B(-69.9%)
-$6.56B(-330.3%)
-$8.27B(-56.0%)
Sep 2021
-
$2.85B(+208.6%)
-$5.30B(+46.7%)
Jun 2021
-
-$2.62B(-35.2%)
-$9.95B(-51.8%)
Mar 2021
-
-$1.94B(+46.0%)
-$6.55B(-34.6%)
Dec 2020
-$4.87B(+69.1%)
-$3.59B(-99.7%)
-$4.87B(-51.8%)
Sep 2020
-
-$1.80B(-332.0%)
-$3.21B(+24.9%)
Jun 2020
-
$775.00M(+405.1%)
-$4.27B(+61.3%)
Mar 2020
-
-$254.00M(+86.8%)
-$11.03B(+30.0%)
Dec 2019
-$15.77B(+29.9%)
-$1.93B(+32.5%)
-$15.77B(+9.4%)
Sep 2019
-
-$2.86B(+52.3%)
-$17.41B(-1.6%)
Jun 2019
-
-$5.99B(-20.2%)
-$17.13B(-8.5%)
Mar 2019
-
-$4.99B(-39.8%)
-$15.79B(+29.8%)
Dec 2018
-$22.49B(-241.1%)
-$3.57B(-38.3%)
-$22.49B(-6.8%)
Sep 2018
-
-$2.58B(+44.5%)
-$21.06B(-7.5%)
Jun 2018
-
-$4.65B(+60.2%)
-$19.58B(-21.1%)
Mar 2018
-
-$11.69B(-447.9%)
-$16.18B(-145.3%)
Dec 2017
-$6.59B(-153.7%)
-$2.13B(-92.8%)
-$6.59B(-0.2%)
Sep 2017
-
-$1.11B(+10.9%)
-$6.58B(-34.5%)
Jun 2017
-
-$1.24B(+41.2%)
-$4.89B(+17.6%)
Mar 2017
-
-$2.11B(+0.5%)
-$5.94B(-128.4%)
Dec 2016
-$2.60B(+31.1%)
-$2.12B(-464.6%)
-$2.60B(-87.5%)
Sep 2016
-
$582.00M(+125.5%)
-$1.39B(+59.3%)
Jun 2016
-
-$2.29B(-286.3%)
-$3.41B(-427.6%)
Mar 2016
-
$1.23B(+235.0%)
-$646.00M(+79.3%)
Dec 2015
-$3.77B(-31.1%)
-$909.00M(+36.9%)
-$3.12B(+37.3%)
Sep 2015
-
-$1.44B(-402.5%)
-$4.97B(-22.9%)
Jun 2015
-
$476.00M(+138.3%)
-$4.05B(-11.6%)
Mar 2015
-
-$1.24B(+55.0%)
-$3.63B(-26.0%)
Dec 2014
-$2.88B(-205.5%)
-$2.77B(-439.0%)
-$2.88B(-177.9%)
Sep 2014
-
-$513.00M(-157.3%)
$3.69B(-47.2%)
Jun 2014
-
$896.00M(+281.0%)
$7.00B(+20.3%)
Mar 2014
-
-$495.00M(-113.0%)
$5.82B(+113.4%)
Dec 2013
$2.73B(+550.6%)
$3.81B(+36.6%)
$2.73B(+212.3%)
Sep 2013
-
$2.79B(+1084.8%)
-$2.43B(+36.0%)
Jun 2013
-
-$283.00M(+92.1%)
-$3.79B(-110.5%)
Mar 2013
-
-$3.58B(-166.1%)
-$1.80B(-529.8%)
Dec 2012
$419.00M(+162.2%)
-$1.35B(-194.6%)
$419.00M(-87.9%)
Sep 2012
-
$1.42B(-16.6%)
$3.46B(+1958.6%)
Jun 2012
-
$1.71B(+225.1%)
-$186.00M(-140.7%)
Mar 2012
-
-$1.36B(-180.7%)
$457.00M(+167.8%)
Dec 2011
-$674.00M(+45.3%)
$1.69B(+176.2%)
-$674.00M(+81.0%)
Sep 2011
-
-$2.22B(-194.4%)
-$3.55B(-2879.8%)
Jun 2011
-
$2.35B(+194.2%)
-$119.00M(+96.2%)
Mar 2011
-
-$2.50B(-111.3%)
-$3.15B(-155.8%)
Dec 2010
-$1.23B(+39.1%)
-$1.18B(-197.8%)
-$1.23B(+44.7%)
Sep 2010
-
$1.21B(+276.9%)
-$2.23B(+34.1%)
Jun 2010
-
-$683.00M(-18.6%)
-$3.38B(-29.8%)
Mar 2010
-
-$576.00M(+73.5%)
-$2.60B(-28.7%)
Dec 2009
-$2.02B(+34.1%)
-$2.18B(-4058.2%)
-$2.02B(-40.1%)
Sep 2009
-
$55.00M(-40.9%)
-$1.45B(-0.7%)
Jun 2009
-
$93.00M(+1760.0%)
-$1.44B(+53.5%)
Mar 2009
-
$5.00M(+100.3%)
-$3.09B(-0.5%)
Dec 2008
-$3.07B(-15.2%)
-$1.60B(-2558.5%)
-$3.07B(-83.7%)
Sep 2008
-
$65.00M(+104.2%)
-$1.67B(+2.1%)
Jun 2008
-
-$1.56B(-7533.3%)
-$1.71B(-179.7%)
Mar 2008
-
$21.00M(+110.6%)
-$611.00M(+77.1%)
Dec 2007
-$2.67B
-$198.00M(-782.8%)
-$2.67B(-6.0%)
Sep 2007
-
$29.00M(+106.3%)
-$2.52B(+12.8%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$463.00M(+77.3%)
-$2.89B(+23.5%)
Mar 2007
-
-$2.04B(-4141.7%)
-$3.77B(-363.2%)
Dec 2006
-$815.00M(+82.0%)
-$48.00M(+86.0%)
-$815.00M(+55.8%)
Sep 2006
-
-$342.00M(+74.6%)
-$1.84B(-14.3%)
Jun 2006
-
-$1.35B(-246.0%)
-$1.61B(-83.0%)
Mar 2006
-
$924.00M(+185.7%)
-$882.00M(+80.6%)
Dec 2005
-$4.54B(-182.0%)
-$1.08B(-871.2%)
-$4.54B(-95.9%)
Sep 2005
-
-$111.00M(+82.0%)
-$2.32B(+33.8%)
Jun 2005
-
-$617.00M(+77.4%)
-$3.50B(+7.8%)
Mar 2005
-
-$2.73B(-339.0%)
-$3.80B(-136.0%)
Dec 2004
-$1.61B(-17.3%)
$1.14B(+188.2%)
-$1.61B(+50.6%)
Sep 2004
-
-$1.30B(-42.2%)
-$3.26B(-51.6%)
Jun 2004
-
-$911.70M(-67.5%)
-$2.15B(-42.8%)
Mar 2004
-
-$544.20M(-7.4%)
-$1.51B(-9.8%)
Dec 2003
-$1.37B(-177.2%)
-$506.50M(-170.6%)
-$1.37B(-70.2%)
Sep 2003
-
-$187.20M(+30.0%)
-$805.90M(-60.1%)
Jun 2003
-
-$267.50M(+34.8%)
-$503.50M(+33.2%)
Mar 2003
-
-$410.30M(-794.2%)
-$753.40M(-142.4%)
Dec 2002
$1.78B(+471.9%)
$59.10M(-48.7%)
$1.78B(+14.3%)
Sep 2002
-
$115.20M(+122.3%)
$1.56B(+32.4%)
Jun 2002
-
-$517.40M(-124.4%)
$1.17B(-28.8%)
Mar 2002
-
$2.12B(+1397.9%)
$1.65B(+445.2%)
Dec 2001
-$478.00M(+4.9%)
-$163.40M(+38.5%)
-$478.00M(-17.2%)
Sep 2001
-
-$265.50M(-536.7%)
-$407.80M(-6.5%)
Jun 2001
-
-$41.70M(-463.5%)
-$382.80M(+19.0%)
Mar 2001
-
-$7.40M(+92.1%)
-$472.80M(+5.9%)
Dec 2000
-$502.70M(+26.3%)
-$93.20M(+61.2%)
-$502.70M(+26.7%)
Sep 2000
-
-$240.50M(-82.6%)
-$685.50M(-26.1%)
Jun 2000
-
-$131.70M(-253.1%)
-$543.60M(+15.7%)
Mar 2000
-
-$37.30M(+86.5%)
-$645.10M(+5.4%)
Dec 1999
-$682.00M(-68.1%)
-$276.00M(-179.9%)
-$682.00M(-51.4%)
Sep 1999
-
-$98.60M(+57.7%)
-$450.40M(-3.4%)
Jun 1999
-
-$233.20M(-214.3%)
-$435.70M(-139.8%)
Mar 1999
-
-$74.20M(-67.1%)
-$181.70M(+55.2%)
Dec 1998
-$405.80M(+23.6%)
-$44.40M(+47.1%)
-$405.80M(+26.4%)
Sep 1998
-
-$83.90M(-503.4%)
-$551.60M(+19.0%)
Jun 1998
-
$20.80M(+107.0%)
-$681.00M(-1.6%)
Mar 1998
-
-$298.30M(-56.8%)
-$670.30M(-26.3%)
Dec 1997
-$530.90M(-29.6%)
-$190.20M(+10.8%)
-$530.90M(-35.3%)
Sep 1997
-
-$213.30M(-777.1%)
-$392.30M(-46.7%)
Jun 1997
-
$31.50M(+119.8%)
-$267.50M(+36.8%)
Mar 1997
-
-$158.90M(-207.9%)
-$423.20M(-3.3%)
Dec 1996
-$409.80M(-83.2%)
-$51.60M(+41.7%)
-$409.80M(+8.7%)
Sep 1996
-
-$88.50M(+28.7%)
-$448.90M(-30.8%)
Jun 1996
-
-$124.20M(+14.6%)
-$343.30M(-10.7%)
Mar 1996
-
-$145.50M(-60.4%)
-$310.20M(-38.7%)
Dec 1995
-$223.70M(+13.3%)
-$90.70M(-630.4%)
-$223.70M(-14.2%)
Sep 1995
-
$17.10M(+118.8%)
-$195.80M(+30.0%)
Jun 1995
-
-$91.10M(-54.4%)
-$279.60M(-14.7%)
Mar 1995
-
-$59.00M(+6.1%)
-$243.80M(+5.5%)
Dec 1994
-$258.08M(-3807.9%)
-$62.80M(+5.8%)
-$258.10M(-38.7%)
Sep 1994
-
-$66.70M(-20.6%)
-$186.10M(-92.3%)
Jun 1994
-
-$55.30M(+24.6%)
-$96.80M(-261.2%)
Mar 1994
-
-$73.30M(-896.7%)
-$26.80M(-306.1%)
Dec 1993
-$6.60M(-105.3%)
$9.20M(-59.3%)
-$6.60M(-10.0%)
Sep 1993
-
$22.60M(+53.7%)
-$6.00M(-287.5%)
Jun 1993
-
$14.70M(+127.7%)
$3.20M(+150.8%)
Mar 1993
-
-$53.10M(-641.8%)
-$6.30M(-105.0%)
Dec 1992
$124.98M(+24.3%)
$9.80M(-69.2%)
$125.00M(+8.5%)
Sep 1992
-
$31.80M(+511.5%)
$115.20M(+38.1%)
Jun 1992
-
$5.20M(-93.4%)
$83.40M(+6.6%)
Mar 1992
-
$78.20M(+414.5%)
$78.20M(-37.4%)
Dec 1991
$100.57M(+142.4%)
-
-
Mar 1991
-
$15.20M(-78.2%)
$124.90M(+12.0%)
Dec 1990
-
$69.80M(+167.4%)
$111.50M(+156.9%)
Sep 1990
-
$26.10M(+89.1%)
$43.40M(+404.7%)
Jun 1990
-
$13.80M(+666.7%)
$8.60M(-79.3%)
Mar 1990
$41.49M(+105.0%)
$1.80M(+5.9%)
$41.50M(+4.5%)
Dec 1989
-
$1.70M(+119.5%)
$39.70M(+4.5%)
Sep 1989
-
-$8.70M(-118.6%)
$38.00M(-18.6%)
Jun 1989
-
$46.70M
$46.70M
Mar 1989
$20.24M(-77.2%)
-
-
Mar 1988
$88.82M
-
-

FAQ

  • What is Amgen Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Amgen Inc.?
  • What is Amgen Inc. annual cash from financing year-on-year change?
  • What is Amgen Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Amgen Inc.?
  • What is Amgen Inc. quarterly cash from financing year-on-year change?
  • What is Amgen Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Amgen Inc.?
  • What is Amgen Inc. TTM cash from financing year-on-year change?

What is Amgen Inc. annual cash from financing?

The current annual cash from financing of AMGN is -$9.41B

What is the all-time high annual cash from financing for Amgen Inc.?

Amgen Inc. all-time high annual cash from financing is $21.05B

What is Amgen Inc. annual cash from financing year-on-year change?

Over the past year, AMGN annual cash from financing has changed by -$30.46B (-144.73%)

What is Amgen Inc. quarterly cash from financing?

The current quarterly cash from financing of AMGN is -$2.67B

What is the all-time high quarterly cash from financing for Amgen Inc.?

Amgen Inc. all-time high quarterly cash from financing is $21.51B

What is Amgen Inc. quarterly cash from financing year-on-year change?

Over the past year, AMGN quarterly cash from financing has changed by -$24.00M (-0.91%)

What is Amgen Inc. TTM cash from financing?

The current TTM cash from financing of AMGN is -$11.84B

What is the all-time high TTM cash from financing for Amgen Inc.?

Amgen Inc. all-time high TTM cash from financing is $21.05B

What is Amgen Inc. TTM cash from financing year-on-year change?

Over the past year, AMGN TTM cash from financing has changed by -$8.23B (-228.10%)
On this page